HEPI gets PAZ patent issuance notification
The patent, titled ‘Composition and Use of Phyto-Percolate for the Treatment of Disease,’ describes the general makeup of PAZ and its ability to address a variety of common
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.
Veeva claims that its Pharma CRM solution combines complete functionality for specialty care, primary care, managed markets and KOL management in a single application, empowering teams to integrate